期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

罗格列酮钠与美卡素对糖尿病早期肾病的疗效观察 被引量：3

下载PDF
导出
摘要 目的观察太罗(罗格列酮钠)对糖尿病早期肾病尿微量清蛋白排泄的影响。方法将80例糖尿病肾病Ⅲ期患者随机分两组。美卡素治疗组40例在给予糖尿病常规治疗基础上加用80mg/日口服,太罗组40例给予在常规治疗基础上加用太罗4mg/日口服,疗程3个月。治疗前后进行相关指标检查。结果两组均可降低糖尿病肾病Ⅲ期患者尿微量清蛋白排泄,两组治疗后尿微量清蛋白排泄率差异无统计学意义。结论应用太罗治疗能有效减低糖尿病早期肾病尿蛋白排泄。
作者 赵海燕 陈立波 罗琼芳 杜泽园
机构地区 广东医学院附属南山医院内分泌科
出处 《重庆医学》 CAS CSCD 2008年第20期2354-2355,共2页 Chongqing medicine
关键词 糖尿病早期肾病(DN) 治疗 太罗(罗格列酮钠)
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献6

  • 1Chan JC, Tomlinson B, Nicholls MG, et al. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non insulin-dependent diabetes [ J ]. Diabet Med, 1996,13:150.
  • 2Mogensen CE, Christensen CK. The diabectic kidney from hyperfiltration andmicroalbumin to end stage renal failure [J]. Med Clin Nor Ame,1998,72:1465.
  • 3Komers R,Vrana A. Thiazolidenediones tools for the research of metabolie syndrome X[J]. Physiol Res, 1998,4 : 215.
  • 4谭正怀,沈映君.高血糖与糖尿病肾病[J].中国临床药理学与治疗学,2002,7(6):565-569. 被引量：14
  • 5Pistrosch F, Herbrig K,Kindel B,et al. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dys function, and microalbuminuria of incipient diabetic ne phropathy in patients[J]. Diabetes,2005,54(7) :2206.
  • 6Arima S, Kohagura K,Takeuchi K, et al. Biphasic vasodilator action of trogltazone on the renal microcirculation [J]. J Am Soc Nephrol,2002,13(2) :342.

二级参考文献27

  • 1D'Agord Schaan B, Lacchini S, Bertoluci MC,et al. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes[J]. Horm Metab Res,2001;33:664-9
  • 2Mogyorosi A, Ziyadeh FN. GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy[J]. Nephrol Dial Transplant,1999;14:2827-9
  • 3Ishii H, Tada H, Isogai S. An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells[J]. Diabetologia,1998;41:362-4
  • 4Heilig CW, Concepcion LA, Riser BL, et al. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype[J]. J Clin Invest ,1995;96:1802-14
  • 5Noh H, Ha H, Yu MR, et al. High glucose increases inducible NO production in cultured rat mesangial cells, possible role in fibronectin production[J]. Nephron,2002;90:78-85
  • 6Phillips AO, Steadman R, Morrisey K, et al. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation[J]. Kidney Int,1997;52:973-84
  • 7Kasajima H, Yamagishi S, Sugai S, et al. Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients[J]. Virchows Arch, 2001;439:46-54
  • 8Iso K, Tada H, Kuboki K, et al. Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in type 2 diabetic patients[J]. J Diabetes Complications,2001;15:241-4
  • 9Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose[J]. Biochem J,1999;15:344:109-16
  • 10Tanji N, Markowitz GS, Fu C, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease[J]. J Am Soc Nephrol ,2000;11:1656-66

共引文献13

同被引文献28

引证文献3

二级引证文献11

重庆医学
2008年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部